Kathleen D. Scott, CFO: ARS Pharmaceuticals SPRY Sell · Filed 25/05/22

Trade details

Type: Insider sale
Amount: $705,000
Shares · price: 50,000 sh · $14.10 a share
Held after: 7,424 sh
Stock: ARS Pharmaceuticals SPRY
Person: Kathleen D. ScottCFO
Trade date: 25/05/20
Filed: 25/05/22
Days to filing: 2 days

Sold 87.1% of holdings

Share of holding sold: 87.1%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/04/20~25/06/19

Kathleen D. Scott's recent trades

Kathleen D. ScottDirector
SellDermata Therapeutics
Sell
Dermata Therapeutics
DRMA
$13
11 sh
$13
Filed 06/16
Traded 06/16
Kathleen D. ScottCFO
Sell10b5-1 planARS Pharmaceuticals
Sell10b5-1 plan
ARS Pharmaceuticals
SPRY
$187.5K
12,500 sh
$187.5K
Filed 25/08/22
Traded 25/08/21
Kathleen D. ScottOfficer
Planned sale10b5-1 planARS Pharmaceuticals
Planned sale10b5-1 plan
ARS Pharmaceuticals
SPRY
$187.5K
12,500 sh
$187.5K
Filed 25/08/21
Traded 25/08/21
Kathleen D. ScottOfficer
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$705K
50,000 sh
$705K
Filed 25/05/20
Traded 25/05/20
Kathleen D. ScottCFO
Sell10b5-1 planARS Pharmaceuticals
Sell10b5-1 plan
ARS Pharmaceuticals
SPRY
$200K
12,500 sh
$200K
Filed 24/10/17
Traded 24/10/16